Aflatoonian Abbas, Eftekhar Maryam, Mohammadian Farnaz, Yousefnejad Fariba
Department of Obstetrics and Gynecology, Research and Clinical Center for Infertility, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Department of Obstetrics and Gynecology, Zanjan University of Medical Sciences, Zanjan, Iran.
Iran J Reprod Med. 2011 Fall;9(4):281-4.
Human fertility has been declined all over the world. Advanced women's age is one of the most important factors in determining the success of reproduction and ageing has negative impact on ART outcome and advanced female age decreases the chance of live birth rates achieved using ART, especially after 40 years of age.
To evaluate ART outcomes regarding to pregnancy, abortion, cycle cancellation and live birth rates in women 40 years and older.
A retrospective study was performed on three hundred-thirteen women undergoing ART cycles in the Madar Hospital in Yazd. Women with age ≥ 40 years who indicated for ART enrolled the study regardless of the infertility type or etiology. In this study, we used data from IVF or ICSI cycles using fresh embryo transfer. Follow up was performed in regard to pregnancy, abortion, cycle cancellation and live birth rates.
The mean age of women was 41.87±1.97 years. Chemical pregnancy rate was 8.6% (27/313) per cycle. Clinical pregnancy rate was 3.8% (12/313) per cycle. Spontaneous abortion was observed in 63% (17/27) of patients with positive pregnancy test. The overall cancellation rate was 23.3% per oocytes retrieval. The overall live birth rate per cycle for all women who initiated an ART cycle at age ≥40 years was 3.2% (10/313) that eight of those women were under 42 years old.
Based on our results, we suggest that women with age 42 years and above should be advised to use other options, including oocyte donation or adoption.
全球人类生育率呈下降趋势。女性年龄增长是决定生殖成功的最重要因素之一,年龄增长对辅助生殖技术(ART)的结果有负面影响,高龄女性使用ART实现活产的几率降低,尤其是40岁以后。
评估40岁及以上女性在ART治疗中妊娠、流产、周期取消和活产率的情况。
对在亚兹德马达尔医院接受ART周期治疗的313名女性进行回顾性研究。年龄≥40岁且适合ART治疗的女性,无论不孕类型或病因如何,均纳入研究。本研究使用新鲜胚胎移植的体外受精(IVF)或卵胞浆内单精子注射(ICSI)周期的数据。对妊娠、流产、周期取消和活产率进行随访。
女性的平均年龄为41.87±1.97岁。每个周期的化学妊娠率为8.6%(27/313)。每个周期的临床妊娠率为3.8%(12/313)。妊娠试验呈阳性的患者中有63%(17/27)发生自然流产。每次取卵的总体取消率为23.3%。所有年龄≥40岁开始ART周期治疗的女性,每个周期的总体活产率为3.2%(10/313),其中8名女性年龄在42岁以下。
根据我们的研究结果,我们建议42岁及以上的女性应考虑使用其他选择,包括卵母细胞捐赠或领养。